Estimating the Costs of Attention-Deficit/Hyperactivity Disorder

Abright, A. Reese

doi:10.1016/j.jaac.2012.07.012

Cited by 6 publications

(11 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…National yearly healthcare costs have ranged from $143 billion to $266 billion, 9 with over half this amount assumed directly by families. 10 Even in previous decades when prevalence rates hovered around 5%, the cost of workday loss in the United States was high for adult patients and for parents of young children with ADHD needing to take time off from work for doctors' visits. 11 Projections across 10 countries indicated that adults with ADHD lost more workdays than did workers without ADHD.…”

Section: ■ Costs Of Adhdmentioning

confidence: 99%

ADHD: Overdiagnosed and overtreated, or misdiagnosed and mistreated?

Manos

Giuliano

Geyer

2017

CCJM

View full text Add to dashboard Cite

show abstract

Section: ■ Costs Of Adhdmentioning

confidence: 99%

ADHD: Overdiagnosed and overtreated, or misdiagnosed and mistreated?

Manos

Giuliano

Geyer

2017

CCJM

View full text Add to dashboard Cite

show abstract

“…Overall, in addition to the human suffering they cause, psychiatric disorders are among the most expensive of all health problems in adults [24, 28], even if evidence regarding the costs of psychiatric disorders has been slow to accumulate, particularly with regard to those that affect children and adolescents [29]. Literature review of the health care and treatment-related ADHD economic impact estimates an annual cost, specifically for children and adolescents, at $14,576 per individual, with a comprehensive range from $36 billion to $52.4 billion considering an ADHD prevalence rate of 5% [30].…”

Section: Introductionmentioning

confidence: 99%

Italian regional health service costs for diagnosis and 1-year treatment of ADHD in children and adolescents

Casadei

Cartabia

Reale

et al. 2017

Int J Ment Health Syst

View full text Add to dashboard Cite

The main aim of this study was to estimate the costs associated with diagnostic assessment and 1-year therapy in children and adolescents enrolled in 18 ADHD reference centres. Data concerning 1887 children and adolescents from the mandatory ADHD registry database during the 2012–2014 period were analysed. The overall diagnostic and treatment costs per patient amounts to €574 and €830, respectively. The ADHD centre, the school as sender, and the time to diagnosis constitute cost drivers. Non-pharmacological therapy resulted as being more expensive for patients concomitantly treated with drugs (€929) compared to those treated with psychological interventions alone (€590; p = 0.006). This study gives the first and reliable estimate of the costs associated with both diagnosis and treatment of ADHD in Italy. Although costs associated with mental disorders are difficult to estimate, continuing efforts are need to define costs and resources to guarantee appropriate care, also for ADHD.Electronic supplementary materialThe online version of this article (doi:10.1186/s13033-017-0140-8) contains supplementary material, which is available to authorized users.

show abstract

“… 1 Attention-deficit/hyperactivity disorder is characterized by difficulty maintaining attention, controlling impulses, and regulating activity level and may be associated with academic and social problems as well as difficulties throughout adulthood. 2 , 3 , 4 , 5 …”

Section: Introductionmentioning

confidence: 99%

Association of Exposure to Endocrine-Disrupting Chemicals During Adolescence With Attention-Deficit/Hyperactivity Disorder–Related Behaviors

et al. 2020

View full text Add to dashboard Cite

Key Points Question Is exposure to endocrine-disrupting chemicals during adolescence a risk factor for behaviors associated with attention-deficit/hyperactivity disorder (ADHD)? Findings In this cross-sectional analysis of data from 205 adolescents participating in a prospective birth cohort study, exposure to select phthalates was associated with an increased risk of ADHD-related behaviors. Associations were strongest for phthalates with antiandrogenic activity. Meaning These findings support the potential importance of exposures to endocrine-disrupting chemicals, especially phthalates, during adolescence as correlates of ADHD-related behaviors.

show abstract

Estimating the Costs of Attention-Deficit/Hyperactivity Disorder

Cited by 6 publications

References 9 publications

ADHD: Overdiagnosed and overtreated, or misdiagnosed and mistreated?

ADHD: Overdiagnosed and overtreated, or misdiagnosed and mistreated?

Italian regional health service costs for diagnosis and 1-year treatment of ADHD in children and adolescents

Association of Exposure to Endocrine-Disrupting Chemicals During Adolescence With Attention-Deficit/Hyperactivity Disorder–Related Behaviors

Contact Info

Product

Resources

About